9267
Fiscal year ends June Quarters are offset from the calendar — Q1 is Jul–Sep

Genky DrugStores Co., Ltd. operates as a holding company managing its group of subsidiaries. The company functions within a single business segment, overseeing the operations of its consolidated subsidiaries without distinct segment reporting. The group's activities are centered on the management and administration of its corporate entities.

Summarised from the annual report, fiscal year ended Jun 2025

Industry Specialty Retail Homepage genkydrugstores.co.jp
Sector Consumer Cyclical IR page genkydrugstores.co.jp
Tags
holding company, pharmaceutical retail, drug stores
Press page —

Metrics

Valuation  
Market cap ¥ 106.017B
Market cap (USD) $ 662.615M
P/E 13.49
PEG 0.74
P/BV 1.68
P/S 0.48
P/OCF 6.25
P/FCF -33.47
Dividend yield 0.38%
Turnover / mcap —
Returns  
ROE 13.7%
ROI 8.6%
ROIC 8.5%
Profit margin 3.6%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 18.2%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 44.4%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Revenue 220.638B 200.786B 184.86B 169.059B 154.64B 142.376B 123.603B 103.897B 94.869B
Net profit 7.875B 7.066B 6.324B 4.764B 4.421B 4.832B 2.755B 2.698B 3.118B
Free cash flow -3.168B -2.51B 2.815B -1.155B -4.431B 3.121B -3.518B -6.423B 75.16M

Figure FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018
Share price 3.335K 3.718K 2.749K 4.239K 3.167K 3.73K 3.361K 2.546K 4.334K
Price performance 12m -0.1 0.35 -0.35 0.34 -0.15 0.11 0.32 -0.41 —

Filed figures

Figure Jun 2018 Jun 2019 Jun 2020 Jun 2021 Jun 2022 Jun 2023 Jun 2024 Jun 2025 Jun 2026
Balance sheet detail
Trade receivables (JPY) 783M 1.12B 2.29B 2.6B 2.8B 3.93B 4.69B 4.84B 5.67B
↳ YoY growth +43.7% +103.8% +13.5% +7.6% +40.2% +19.4% +3.2% +17.2%
↳ 5y CAGR +38.0% +33.0% +16.1% +16.9%
Other receivables (JPY) 3.81B 1.13B 1.46B 1.82B 2.01B 2.26B 2.41B 2.58B 3.41B
Borrowings, current (JPY) 5.14B 5.91B 5.92B 6.82B 10.2B 11.2B 8.09B 8.41B 9.48B
Borrowings, non-current (JPY) 8.35B 15.7B 24.1B 21.7B 20.8B 20.9B 22.4B 25.8B 30B
Lease liabilities (JPY) 480M 405M 361M 56M 25.9M 166M 152M 145M 139M
Cash and deposits (JPY) 2.23B 2.44B 6.62B 7.91B 5.44B 5.33B 5.9B 6.22B 7.87B
Intangible assets (JPY) 265M 291M 303M 394M 375M 363M 378M 307M 266M
Net debt (borrowings + leases - cash) (JPY) 11.7B 19.6B 23.8B 20.6B 25.5B 27B 24.8B 28.2B 31.6B
Cash flow detail
Operating cash flow (JPY) 5.37B 4.3B 7.41B 12.1B 6.08B 8.77B 13.3B 12.6B 17B
Purchases of property, plant and equipment (JPY) -5.2B -10.6B -10.9B -8.81B -10.5B -9.89B -10.3B -15.1B -20.1B
Purchases of intangible assets (JPY) -89.2M -78.6M -76.7M -142M -43.9M -37M -163M -15M -42M
Change in receivables (cash effect) (JPY) 15.1M -342M -1.17B -309M -198M -1.13B -759M -151M -830M
Change in inventories (cash effect) (JPY) -1.87B -2.76B -1.53B -1.1B -1.52B -1.58B -1.6B -3.04B -1.58B
Change in payables (cash effect) (JPY) 1.03B 921M 3.48B 2.35B 949M 1.63B 2B 2.54B 4.12B
Dividends paid (cash effect) (JPY) -369M -387M -380M -380M -379M -379M -380M -395M -395M
Share buybacks (cash effect) (JPY) -540,000 -788M -131,000 -671,000 -230,000 0.00 0.00 0.00 0.00
Interest paid (cash effect) (JPY) -40.4M -50.3M -68.1M -67.2M -74.9M -71M -105M -216M -306M
Income taxes paid (cash effect) (JPY) -1.22B -1.5B -1.55B -1.64B -1.99B -2.04B -1.79B -3.16B -2.73B
Share-based compensation (JPY) — — 9.51M — — — — — —
Operating cash flow before change in receivables (JPY) 5.35B 4.64B 8.58B 12.4B 6.27B 9.9B 14B 12.7B 17.8B
Free cash flow (OCF - PPE - intangibles) (JPY) 75.2M -6.42B -3.59B 3.12B -4.43B -1.16B 2.82B -2.51B -3.17B
Income detail
Total comprehensive income (JPY) 3.16B 2.68B 2.75B 4.85B 4.39B 4.8B 6.32B 7.06B 7.89B
Comprehensive income to owners (JPY) 3.16B 2.68B 2.75B 4.85B 4.39B 4.8B 6.32B 7.06B 7.89B
Provision for credit losses (JPY) — — 286M — — — — — —
Credit cost ratio (credit losses / average receivables) (%) — — 9.5% — — — — — —
Reported Sep 10, 2018 Sep 9, 2019 Sep 7, 2020 Sep 6, 2021 Sep 12, 2022 Sep 20, 2023 Sep 13, 2024 Sep 10, 2025 Oct 30, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

2027年6月期 第1四半期説明補足資料 Bull 0 Bear 0 Routine
2027年6月期 第1四半期決算説明資料 Bull 3 Bear 0 Results

Prompts

Genky DrugStores Co., Ltd. (ticker 9267), listed in Japan.

ETFs Holding Genky DrugStores Co., Ltd.

ETF Weight in ETF Shares Market value As of
DXIV 0.02% 1,600 $ 37.373K Nov 12, 2026
DFIS 0.01% 29,800 $ 696.079K Nov 12, 2026
AVDV 0.01% 78,200 $ 1.914M Nov 16, 2026
AVSD 0.01% 1,500 $ 36.705K Nov 16, 2026
AVDS 0.01% 1,700 $ 41.599K Nov 16, 2026
DFSI 0.00% 1,800 $ 42.045K Nov 12, 2026
DFIC 0.00% 20,300 $ 474.174K Nov 12, 2026
DFAX 0.00% 11,200 $ 261.614K Nov 12, 2026
DFAI 0.00% 15,600 $ 364.39K Nov 12, 2026
AVDE 0.00% 26,200 $ 641.109K Nov 16, 2026